Oncologists Accepting Molina Healthcare in MassachusettsPage 6

Otto Metzger, M.D.

Director, International Strategic Initiatives; Assistant Professor of Medicine, Harvard Medical School

Oncology

Rochelle Scheib, MD

Professor of Medicine, Harvard Medical School

Oncology

Matthew Oser, M.D./PH.D.

Assistant Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School where he runs a research laboratory focused on small cell lung cancer and is a; Associate Professor of Medicine, Harvard Medical School

Oncology

Rizwan Haq, MD, PHD

Assistant Professor, Harvard Medical School

Oncology

Shayna Sarosiek, MD

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Ting Bao, M.D.

Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria

Oncology

David Jackman, M.D.

Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician

Oncology

Arielle Langer, MD, MPH

Instructor in Medicine, Harvard Medical School; Assistant Professor of Medicine, Brigham and Women's Hospital

Oncology

Christopher Lathan, M.D. M.S. M.P.H.

Chair at Dana Farber, and he serves as Dana-Farber’s Chief Clinical Access Officer. He is the Founding Director of Dana-Farber’s Cancer Care Access Program; Chief Medical Officer and Medical Director of Dana-Farber Cancer Institute’s Regional Campuses and currently serves as the chair for American Society of Cl

Oncology

Michael Serzan, MD

Instructor of Medicine at Harvard Medical School.; Chief Resident at Medstar Georgetown University Hospital. Dr. Serzan joined the Lank Center for Genitourinary Oncology in 2022 and has expertise in t

Oncology

Kenneth Kehl, MD

Director of Clinical Research; Assistant Professor of Medicine, Harvard Medical School

Oncology

Kerry Reynolds, MD

Assistant Professor of Medicine, Harvard Medical School; Clinical Director, Inpatient Oncology, Massachusetts General Hospital; Director, Severe Immunotherapy Complications Service, Mass General Brigham

Oncology

Jennifer Temel, MD

Professor of Medicine at Harvard Medical School, Clinical Director of Thoracic Oncology at Massachusetts General Hospital, Co-Director of the Cancer Outcomes Research and Education Program at Massachusetts General Hospital Cancer Center

Oncology

Jia Luo, MD

Assistant Professor of Medicine, Harvard Medical School; Chief Resident in Internal Medicine

Oncology

Oreofe Odejide, MD

Assistant Professor of Medicine, Harvard Medical School

Oncology

Virginia Volpe, M.D.

Instructor of Medicine at Harvard Medical School. She is board certified in Internal Medicine, Hematology, and Medical Oncology. She completed her r

Oncology

Cesar Castro, M.D., M.SC.

Director, Gynecologic Oncology Program; Associate Professor of Medicine, Harvard Medical School; Chair, Mass General Brigham Phase 1 Cancer Clinical Trials

Oncology

Daniel Haber, MD PHD

Oncology

Alok Tewari, M.D., PH.D.

Instructor in Medicine, Harvard Medical School

Oncology

Amar Kelkar, M.D.

Physician in Medical Oncology, Dana-Farber Cancer Institute; Associate Physician, Brigham and Women's Hospital; Instructor in Medicine, Harvard Medical School

Oncology